======= SCUBE3 =======
== Gene Information ==
* **Official Symbol**: SCUBE3
* **Official Name**: signal peptide, CUB domain and EGF like domain containing 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=222663|222663]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8IX30|Q8IX30]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SCUBE3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SCUBE3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614708|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the signal peptide, complement subcomponents C1r/C1s, Uegf, bone morphogenetic protein-1 and epidermal growth factor-like domain containing protein family. Overexpression of this gene in human embryonic kidney cells results in secretion of a glycosylated form of the protein that forms oligomers and tethers to the cell surface. This gene is upregulated in lung cancer tumor tissue compared to healthy tissue and is associated with loss of the epithelial marker E-cadherin and with increased expression of vimentin, a mesenchymal marker. In addition, the protein encoded by this gene is a transforming growth factor beta receptor ligand, and when secreted by cancer cells, it can be cleaved in vitro to release the N-terminal epidermal growth factor-like repeat domain and the C-terminal complement subcomponents C1r/C1s domain. Both the full length protein and C-terminal fragment can bind to the transforming growth factor beta type II receptor to promote the epithelial-mesenchymal transition and tumor angiogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014].
* **UniProt Summary**: Binds to TGFBR2 and activates TGFB signaling. In lung cancer cells, could serve as an endogenous autocrine and paracrine ligand of TGFBR2, which could regulate TGFBR2 signaling and hence modulate epithelial-mesenchymal transition and cancer progression. {ECO:0000269|PubMed:21441952}.
|GCC2 GCC3|
|EGF|
|EGF 3|
|CUB|
|cEGF|
|EGF CA|
|positive regulation of smoothened signaling pathway|
|extracellular matrix disassembly|
|regulation of smoothened signaling pathway|
|protein heterooligomerization|
|protein homooligomerization|
|extracellular matrix organization|
|extracellular structure organization|
|cellular component disassembly|
|protein complex oligomerization|
|cell surface|
|calcium ion binding|
|protein-containing complex assembly|
|extracellular space|
|positive regulation of signal transduction|
|positive regulation of cell communication|
|positive regulation of signaling|
|protein-containing complex subunit organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.7|
|[[:results:exp148|SB202190 10μM R03 exp148]]|1.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8795
* **Expression level (log2 read counts)**: 2.71
{{:chemogenomics:nalm6 dist.png?nolink |}}